Am80-Encapsulated Lipid Nanoparticles, Developed with the Aim of Achieving Alveolar Regeneration, Have an Improvement Effect on Pulmonary Emphysema
Open Access
- 22 December 2022
- journal article
- research article
- Published by MDPI AG in Pharmaceutics
- Vol. 15 (1) , 37
Abstract
Chronic obstructive pulmonary disease (COPD) is characterized by chronic bronchitis and emphysema, and current drug treatments target its symptoms. Thus, the development of a therapeutic drug to repair alveolar destruction is urgently needed. Our previous research revealed that the synthetic retinoic acid Am80 (1.0 mg/kg) showed a repairing effect on collapsed alveoli in a mouse model of elastase-induced emphysema. However, a further reduction in the dose is desirable to facilitate the development of a powder inhalation formulation for clinical application. We, therefore, focused on SS-OP to deliver Am80 efficiently. As a result, 0.01 mg/kg of Am80-encapsulated SS-OP nanoparticles repaired collapsed alveoli and improved the respiratory function in the mouse model of elastase induced emphysema. The results suggested that, with the use of SS-OP, the Am80 dose could be reduced. This could contribute to the development of a powder inhalation system as a curative medicine for COPD.Keywords
Funding Information
- NOF CORPORATION (Tokyo, Japan)
This publication has 41 references indexed in Scilit:
- Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2013
- Alveolar fractal box dimension inversely correlates with mean linear intercept in mice with elastase-induced emphysemaInternational Journal of Chronic Obstructive Pulmonary Disease, 2012
- Lung function decline in COPDInternational Journal of Chronic Obstructive Pulmonary Disease, 2012
- SHH propagates distal limb bud development by enhancing CYP26B1-mediated retinoic acid clearance via AER-FGF signallingDevelopment, 2011
- Is a regenerative approach viable for the treatment of COPD?British Journal of Pharmacology, 2011
- Isolation of alveolar epithelial type II progenitor cells from adult human lungsLaboratory Investigation, 2011
- PML-RARα inhibitors (ATRA, tamibaroten, arsenic troxide) for acute promyelocytic leukemiaInternational Journal of Clinical Oncology, 2007
- Differentiated Human Alveolar Epithelial Cells and Reversibility of their Phenotype In VitroAmerican Journal of Respiratory Cell and Molecular Biology, 2007
- Retinoic acid in alveolar development, maintenance and regenerationPhilosophical Transactions of the Royal Society B: Biological Sciences, 2004
- Localization of the RAR interaction domain of cellular retinoic acid binding protein-IIJournal of Molecular Biology, 2001